Central nervous system disorders after hematopoietic stem cell transplantation: a prospective study of the Infectious Diseases Working Party of EBMT
Jazyk angličtina Země Německo Médium print-electronic
Typ dokumentu časopisecké články
PubMed
31664549
DOI
10.1007/s00415-019-09578-5
PII: 10.1007/s00415-019-09578-5
Knihovny.cz E-zdroje
- MeSH
- cerebrovaskulární poruchy epidemiologie etiologie MeSH
- dítě MeSH
- dospělí MeSH
- infekce centrálního nervového systému epidemiologie etiologie MeSH
- kojenec MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- předškolní dítě MeSH
- prospektivní studie MeSH
- senioři MeSH
- transplantace hematopoetických kmenových buněk škodlivé účinky statistika a číselné údaje MeSH
- Check Tag
- dítě MeSH
- dospělí MeSH
- kojenec MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- předškolní dítě MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
We performed a prospective study to evaluate the types and characteristics of central nervous system (CNS) disorders in patients after hematopoietic stem cell transplantation. The study included 163 episodes of CNS disorders of which 58 (36%) were infections. Proven or probable infections were documented in 34 patients and included fungi (n = 10, 29%), viruses (n = 12, 35%), Toxoplasma spp. (n = 9, 27%) and bacteria (n = 3, 9%). Non-infectious neurological disorders (n = 105, 64%) frequently encompassed metabolic/drug-induced abnormalities (n = 28, 27%) or cerebral vascular events (n = 22, 21%). Median onset times were later for infectious (day + 101) vs non-infectious neurological disorders (day + 50, p = 0.009). An unremarkable cranial CT scan was found in 33% of infection episodes. Absence of cerebrospinal fluid pleocytosis despite a normal or increased peripheral blood white blood cell count occurred in 26% of infections. Day-30 mortality rates were significantly higher for fungal (87%) vs non-fungal infections (40%, p < 0.001). Significantly higher mortality rates were also documented for cerebral vascular events than for other non-infectious disorders (86% vs 34%, p < 0.001). Our prospective study shows that diagnostic findings in CNS infections might differ between hematopoietic stem cell transplant recipients and immunocompetent hosts. Special awareness and timely initiation of adequate diagnostics are crucial to improve the prognosis of these patients.
Azienda Ospedaliera Universitaria Careggi Florence Italy
Clinic for Hematology and Oncology Carl Thiem Klinikum Thiemstr 111 03048 Cottbus Germany
Department of Internal Medicine 2 University Hospital Würzburg Würzburg Germany
Department of Microbiology Immunology and Transplantation KU Leuven Leuven Belgium
Department of Pediatric Hematology and Oncology Collegium Medicum UMK Bydgoszcz Poland
Department of Pediatrics Hadassah Hebrew University Medical Center Jerusalem Israel
Department of Stem Cell Transplantation University Medical Center Eppendorf Hamburg Germany
Division of Infectious Diseases University of Genova DISSAL Genoa Italy
EBMT Data Office Leiden The Netherlands
Hematopoietic Stem Cell Unit Transplantation IRCCS Instituto G Gaslini Genova Italy
Hospital de la Santa Creu i Sant Pau Autonomous University of Barcelona Barcelona Spain
Hospital Universitari 1 Politècnic La Fe Valencia Spain
IRCCS Ospedale Policlinico San Martino Genoa Italy
Karolinska University Hospital and Karolinska Institutet Stockholm Sweden
Nottingham University Hospital Nottingham UK
Zobrazit více v PubMed
PLoS One. 2013 Oct 04;8(10):e77805 PubMed
Clin Infect Dis. 1994 Sep;19(3):402-8 PubMed
Ann Oncol. 2016 Jul;27(7):1207-25 PubMed
Bone Marrow Transplant. 2000 Feb;25(3):301-7 PubMed
Bone Marrow Transplant. 2018 Feb;53(2):199-206 PubMed
Bone Marrow Transplant. 2015 Aug;50(8):1030-6 PubMed
Haematologica. 2011 Jan;96(1):142-9 PubMed
Epidemiol Infect. 2010 Jun;138(6):783-800 PubMed
Mycoses. 2019 Mar;62(3):252-260 PubMed
Neurology. 2013 Apr 9;80(15):1430-8 PubMed
Clin Lymphoma Myeloma Leuk. 2015 Oct;15(10):606-11 PubMed
Neurology. 2008 Mar 18;70(12):943-7 PubMed
Clin Infect Dis. 2005 Jan 1;40(1):67-78 PubMed
Neurology. 1998 May;50(5):1441-5 PubMed
Bone Marrow Transplant. 2011 Feb;46(2):273-7 PubMed
Clin Infect Dis. 2008 Jun 15;46(12):1813-21 PubMed
Neural Regen Res. 2018 Jun;13(6):945-954 PubMed
Mycoses. 2007 May;50(3):196-200 PubMed
Bone Marrow Transplant. 2010 Jul;45(7):1181-8 PubMed
Neurology. 2006 Dec 12;67(11):1990-7 PubMed
Bone Marrow Transplant. 2019 Aug;54(8):1354-1360 PubMed
Antimicrob Agents Chemother. 2016 Aug 22;60(9):5600-3 PubMed
Clin Infect Dis. 2013 Sep;57(5):671-81 PubMed
Lancet Neurol. 2018 Apr;17(4):362-372 PubMed
Clin Infect Dis. 2009 Jan 15;48(2):e9-e15 PubMed
J Clin Microbiol. 2014 Mar;52(3):1016-9 PubMed
Blood. 2005 Oct 15;106(8):2641-5 PubMed
Semin Neurol. 2010 Jul;30(3):296-310 PubMed
Neurology. 2003 Mar 11;60(5):842-8 PubMed
Brain Imaging Behav. 2016 Jun;10(2):486-96 PubMed
Infect Drug Resist. 2013 Oct 22;6:163-74 PubMed